Co-Diagnostics, Inc., a Utah corporation, announced two developments aimed at improving global readiness for Ebola and other emerging viral threats. The company’s India joint venture, CoSara Diagnostics, has shipped SARAGENE Bundibugyo Virus Test kits to an independent laboratory after a request from C‑CAMP, a Department of Biotechnology-supported innovation platform. The...